Faculty

Institution

Unit

Venue

Joseph Celestino

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

NoneJoseph Celestino is currently serving as a Gynecologic Oncology And Reproductive Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joseph Celestino

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

gynecology gynecologic oncology oncology ovarian cancer gynecologic cancers cancer research pathology cancer biology tumor biology cell biology oncogenes cancer treatment cancer cells molecular diagnostics health sciences cancer immunotherapy molecular cancer cancer genetics medicinal research cancer care molecular pathology cancer management endocrine-related cancers cancer detection cancer imaging clinical proteomics obstetrics and gynaecology tumor targeting malignant disease tumoral pathology brain tumor research reproductive medicine surgical oncology pharmacotherapy gliomas endocrinology enzyme inhibition cancer screening endometrial hyperplasia endometrial cancer cellular therapy treatment and prevention signaling pathways disease detection cell detection novel platform obstetrics treatment effects tumor suppressors detection technique hormonal receptor clinical immunology endometrial cancers neuroinflammation cell proliferation neural stem cells cancer growth metabolic remodeling viral oncology gene transfer female reproductive system metabolic complications cytokines receptor tyrosine kinases neural progenitors cell lines ovarian carcinoma epha2 expression molecular analysis estrogen-induced proliferation obese rat endometrium obesity-associated endometrial proliferation oral mtor inhibition early‐stage ovarian cancer mek inhibition ovarian epithelial cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1041: Extracellular Vesicle-Associated Noncanonical Orfs as Biomarkers of Surgical Outcome and Chemoresistance in Ovarian Cancer. Cancer Research (2026)

extracellular microvesiclestumor biologygynecologic oncologyabstract 1041surgical outcomegynecologic cancersoncologyoncogenescancer cellscancer biologypathologygynecologyovarian cancercell biology

Abstract 3907: Molecular Determinants of Response in Laparoscopically Triaged Advanced Ovarian Cancer.. Cancer Research (2026)

gynecological surgerymolecular cancergynecologic oncologysurgical oncologyabstract 3907molecular determinantsmolecular pathologyadvanced ovarian cancergynecologic cancersoncologyoncogenespathologygynecologyovarian cancer

Abstract 6522: Novel Serum Biomarkers That Detect Ovarian Cancer Recurrence Earlier Than Ca125. Cancer Research (2026)

biomarker targetbiomarkersabstract 6522biomarker discoverygynecologic oncologyovarian cancer recurrencemolecular diagnosticsprognostic biomarkersnovel serum biomarkersgynecologyovarian cancercell biology

Expression of Antibody Drug Conjugate Target Antigens in Neuroendocrine Carcinoma of the Cervix. Gynecologic Oncology (2026)

tumor targetinggynecologic oncologycancer immunotherapygynecologic cancersoncologycervical cancergynecologyimmunotherapy

Expression of Antibody Drug Conjugate Target Antigens in Ovarian Sex Cord Stromal Tumors. Gynecologic Oncology (2026)

tumoral pathologymalignant diseasegynecologic oncologycancer immunotherapytherapeutic targetsgynecologic cancerscancer cellspathologygynecologyovarian cancer

Integrating Circulating Tumor Dna and Second-Look Laparoscopy for Minimal Residual Disease Detection and Survival Prediction in Ovarian Cancer. Gynecologic Oncology (2026)

survival predictionbiomarkerssecond-look laparoscopygynecological surgerygynecologic oncologysurgical oncologycancer imaginggynecologic cancersoncologymolecular diagnosticsprognostic biomarkerspathologygynecologyovarian cancercancer detection

Supplementary Figure S2 From Combination Therapy With Copanlisib and Niraparib in Patients With Recurrent Endometrial and Ovarian Cancer (Copanira): Efficacy, Toxicity, and Translational Insights. (2026)

endocrine-related cancerspharmacologygynecologic oncologytherapeutic targetsgynecologic cancersoncologyclinical endpointcancer treatmentjama oncologycombination therapygynecologyovarian cancersupplementary figure s2

Tumor-Informed Liquid Biopsy Detection of Structural Variants in High Grade Serous Ovarian Cancer. Oncoscience (2026)

gynecologic oncologymolecular diagnosticsoncologytumor heterogeneitypathologygynecologyovarian cancercancer detection

Abstract 6520: Intratumoral Microbiome Profiling Using High-Depth Whole-Genome Sequencing Highlighted Cutibacterium Acnes in Chemoresistance in Ovarian Cancer. Cancer Research (2025)

microbiomeovarian cancerhigh throughput sequencingsystems biologymetagenomicsgynecologic oncologyclinical microbiologyenvironmental microbiologymicrobial geneticshigh-depth whole-genome sequencingmolecular diagnosticsdysbiosisbacteriaabstract 6520microbiology

Author Correction: Ppp2r1a Mutations Portend Improved Survival After Cancer Immunotherapy. Nature (2025)

author correctionmedicinecancer geneticscancer researchmolecular cancercancer genomicsoncologyoncogenespathologymolecular medicine

1
2
3
4
5
11
10 / page

Joseph Celestino

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Gynecologic Oncology And Reproductive Medicine

NoneJoseph Celestino is currently serving as a Gynecologic Oncology And Reproductive Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joseph Celestino

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 1041: Extracellular Vesicle-Associated Noncanonical Orfs as Biomarkers of Surgical Outcome and Chemoresistance in Ovarian Cancer. Cancer Research (2026)

extracellular microvesiclestumor biologygynecologic oncologyabstract 1041surgical outcomegynecologic cancersoncologyoncogenescancer cellscancer biologypathologygynecologyovarian cancercell biology

Abstract 3907: Molecular Determinants of Response in Laparoscopically Triaged Advanced Ovarian Cancer.. Cancer Research (2026)

Abstract 6522: Novel Serum Biomarkers That Detect Ovarian Cancer Recurrence Earlier Than Ca125. Cancer Research (2026)

Expression of Antibody Drug Conjugate Target Antigens in Neuroendocrine Carcinoma of the Cervix. Gynecologic Oncology (2026)

tumor targetinggynecologic oncologycancer immunotherapygynecologic cancersoncologycervical cancergynecologyimmunotherapy

Expression of Antibody Drug Conjugate Target Antigens in Ovarian Sex Cord Stromal Tumors. Gynecologic Oncology (2026)

tumoral pathologymalignant diseasegynecologic oncologycancer immunotherapytherapeutic targetsgynecologic cancerscancer cellspathologygynecologyovarian cancer

Integrating Circulating Tumor Dna and Second-Look Laparoscopy for Minimal Residual Disease Detection and Survival Prediction in Ovarian Cancer. Gynecologic Oncology (2026)

Tumor-Informed Liquid Biopsy Detection of Structural Variants in High Grade Serous Ovarian Cancer. Oncoscience (2026)

gynecologic oncologymolecular diagnosticsoncologytumor heterogeneitypathologygynecologyovarian cancercancer detection

Abstract 6520: Intratumoral Microbiome Profiling Using High-Depth Whole-Genome Sequencing Highlighted Cutibacterium Acnes in Chemoresistance in Ovarian Cancer. Cancer Research (2025)

Author Correction: Ppp2r1a Mutations Portend Improved Survival After Cancer Immunotherapy. Nature (2025)

author correctionmedicinecancer geneticscancer researchmolecular cancercancer genomicsoncologyoncogenespathologymolecular medicine

1
2
3
4
5
11
10 / page